{"transactions":[{"id":762583,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":43932,"kind":"person","name":"LEDGER STEVEN A","position":1,"cik":"0001090206","reported_name":"LEDGER STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-05-27T19:55:18.000Z","date":"2026-05-26","kind":"grant","planned":false,"acquired":true,"shares":10100,"price":1.93,"value":19493.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reflects the weighted average purchase price of multiple transactions ranging from a low purchase price of $1.87 per share to a high purchase price of $1.95 per share. Upon the written request of the SEC, the Issuer or a security holder of the Issuer, the reporting person agrees to provide the number of shares sold at each price."}],"balance_after":10100,"source":{"system":"sec-edgar","filing":"0001090206-26-000007","document":"wk-form4_1779911715.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090206/000109020626000007/wk-form4_1779911715.xml","form_type":"4"}},{"id":764436,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":43932,"kind":"person","name":"LEDGER STEVEN A","position":1,"cik":"0001090206","reported_name":"LEDGER STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-05-26T23:37:17.000Z","date":"2026-05-21","kind":"grant","planned":false,"acquired":true,"shares":380825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Unless otherwise terminated as provided in the optionee's option agreement, 12/48ths of the shares subject to the option shall vest twelve months after the Vesting Commencement Date, and 1/48th of the shares subject to the option shall vest on the same calendar day of each subsequent month thereafter until the shares subject to the option are fully vested."}],"balance_after":380825,"derivative":{"exercise_price":1.89,"expiration_date":"2036-05-21","underlying":"Common Stock","underlying_shares":380825},"source":{"system":"sec-edgar","filing":"0001090206-26-000005","document":"wk-form4_1779838635.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090206/000109020626000005/wk-form4_1779838635.xml","form_type":"4"}},{"id":902003,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":43932,"kind":"person","name":"LEDGER STEVEN A","position":1,"cik":"0001090206","reported_name":"LEDGER STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2026-02-17T13:20:35.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":230100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Unless otherwise terminated as provided in the optionee's option agreement, 12/48ths of the shares subject to the option shall vest twelve months after the Vesting Commencement Date, and 1/48th of the shares subject to the option shall vest on the same calendar day of each subsequent month thereafter until the shares subject to the option are fully vested."}],"balance_after":230100,"derivative":{"exercise_price":2.76,"expiration_date":"2036-02-03","underlying":"Common Stock","underlying_shares":230100},"source":{"system":"sec-edgar","filing":"0001090206-26-000003","document":"wk-form4_1771334433.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090206/000109020626000003/wk-form4_1771334433.xml","form_type":"4"}},{"id":1186979,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":43932,"kind":"person","name":"LEDGER STEVEN A","position":1,"cik":"0001090206","reported_name":"LEDGER STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-04-01T20:06:08.000Z","date":"2025-03-28","kind":"other","planned":false,"acquired":true,"shares":95730,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pro rata distribution from Ki Partners LLC, of which the Reporting Person is a manager."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"In prior reports, the Reporting Person reported beneficial ownership of 227,927 shares of the Issuers common stock held by Ki Partners LLC."}],"balance_after":95730,"source":{"system":"sec-edgar","filing":"0001628280-25-015888","document":"wk-form4_1743537960.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090206/000162828025015888/wk-form4_1743537960.xml","form_type":"4"}},{"id":1410160,"issuer":{"id":9581,"kind":"organization","name":"Serina Therapeutics, Inc."},"owners":[{"id":43932,"kind":"person","name":"LEDGER STEVEN A","position":1,"cik":"0001090206","reported_name":"LEDGER STEVEN A","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-09-11T20:30:26.000Z","date":"2024-09-09","kind":"grant","planned":false,"acquired":true,"shares":376388,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest as to 12.5% of the underlying shares on March 9, 2025 and thereafter in substantially equal monthly installments such that the stock options shall be fully vested on the fourth anniversary of the grant date, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates."}],"balance_after":490350,"derivative":{"exercise_price":7.4,"expiration_date":"2034-09-09","underlying":"Common Stock","underlying_shares":376388},"source":{"system":"sec-edgar","filing":"0001493152-24-035804","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1090206/000149315224035804/ownership.xml","form_type":"4"}}]}